Protalix BioTherapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference
/PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American:PLX), a biopharmaceutical company focused on the development, production and commercialization of...